You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 7, 2025

Drug Price Trends for NDC 65862-0898


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 65862-0898

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC: 65862-0898

Introduction

When analyzing the market and projecting prices for a specific drug, such as the one identified by the National Drug Code (NDC) 65862-0898, it is crucial to consider several factors, including current market trends, competition, regulatory environment, and economic projections.

Understanding NDC 65862-0898

To begin, it is essential to identify the drug associated with the NDC 65862-0898. However, the provided sources do not specifically mention this NDC. Typically, this code would correspond to a specific drug product, including its dosage form, strength, and manufacturer.

General Market Trends in Pharmaceuticals

Drug Price Inflation

Recent projections indicate that drug prices are expected to rise. According to Vizient, Inc., drug price inflation is projected to grow at 3.8% in the latest Pharmacy Market Outlook, driven in part by specialty pharmacy and the increasing utilization of certain medications like weight loss drugs and gene therapies[2].

Specialty Pharmaceuticals

Specialty pharmaceuticals, which treat high-cost, complex, or chronic conditions, are a significant driver of this price increase. These medications often have high development costs and limited competition, contributing to higher prices. For instance, weight loss drugs like semaglutide and tirzepatide have seen significant increases in spending and utilization[2].

Competition and Generics

Impact of Generics

The introduction of generic versions of drugs can significantly impact pricing. For example, the generic version of fingolimod saw a price reduction of 84% to 97% from its starting price due to competition in the generics market[3]. However, without specific data on the drug associated with NDC 65862-0898, it is unclear whether generic competition will affect its pricing.

Regulatory Environment

Transparency and Reporting

Regulatory requirements for drug price transparency can influence market dynamics. Programs aimed at increasing transparency, such as the Prescription Drug Price Transparency Program, help in understanding the reasons behind price increases. However, the quality of information submitted by manufacturers can be variable, making it challenging to determine the exact reasons for high prices or price increases[3].

Economic Projections

Pharmacy Market Outlook

Projections for the pharmacy market, such as those provided by Vizient, are based on historical spend data and anticipated changes in the market. For the period from July 1, 2024, through June 30, 2025, Vizient projects a 3.8% increase in drug prices, with specialty medications expected to see a 4.18% price increase[2].

Price Projections for NDC 65862-0898

Without specific data on the drug associated with NDC 65862-0898, it is challenging to make precise price projections. However, here are some general considerations:

If It's a Specialty Drug

  • If the drug is a specialty medication, it is likely to follow the trend of increasing prices, potentially at a rate similar to or higher than the overall 4.18% projected for specialty medications[2].

If It's a Generic Drug

  • If the drug is a generic, its price could be influenced by competition in the generics market. Prices might stabilize or decrease if multiple generic versions are available, similar to the case of fingolimod[3].

If It's a Branded Drug

  • For branded drugs, prices are often higher due to patent protection and limited competition. These drugs may see price increases aligned with the overall market trend of 3.8% or higher, depending on the specific market conditions and the drug's lifecycle stage.

Key Takeaways

  • Market Trends: Drug prices are projected to increase, driven by specialty pharmaceuticals and other high-cost medications.
  • Competition: The presence of generic versions can significantly reduce prices, but this depends on the specific drug and market conditions.
  • Regulatory Environment: Transparency programs can help in understanding price dynamics but may face challenges in data quality.
  • Economic Projections: Specialty medications are expected to see higher price increases than the overall market average.

FAQs

  1. What is driving the increase in drug prices?

    • The increase is largely driven by specialty pharmaceuticals, including weight loss drugs and gene therapies, as well as the expanding use of these medications[2].
  2. How do generic drugs impact market prices?

    • Generic drugs can significantly reduce prices due to competition, as seen with the generic version of fingolimod, which saw an 84% to 97% price reduction[3].
  3. What role does regulatory transparency play in drug pricing?

    • Regulatory transparency programs help in understanding the reasons behind price increases, but they often face challenges due to variable data quality submitted by manufacturers[3].
  4. How are biosimilars expected to affect the market?

    • Biosimilars are expected to grow in market share, particularly as pharmacy benefit managers finalize their formulary strategies. However, they may not immediately replace branded drugs like Humira until mandated at the payer level[2].
  5. What is the projected price increase for specialty medications?

    • Specialty medications are projected to see a 4.18% price increase from July 1, 2024, through June 30, 2025[2].

Sources

  1. CDC - IIS | Code Sets | NDC | Vaccines
  2. Vizient, Inc. - Pharmacy Market Outlook
  3. Oregon Department of Consumer and Business Services - Prescription Drug Price Transparency Program results and annual report 2023
  4. FDA.Report - NDC 65862-528
  5. DrugPatentWatch - Latest drug prices and trends for NDC 65862-0835

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.